Exact Mass: 530.3243

Exact Mass Matches: 530.3243

Found 500 metabolites which its exact mass value is equals to given mass value 530.3243, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Kukoamine A

(Z)-3-(3,4-dihydroxyphenyl)-N-(3-{[4-({3-[(Z)-[3-(3,4-dihydroxyphenyl)-1-hydroxypropylidene]amino]propyl}amino)butyl]amino}propyl)propimidic acid

C28H42N4O6 (530.3104)

Kukoamine A is an alkaloid from the root bark of Lycium chinense (Chinese boxthorn Kukoamine A is an amine. Kukoamine A is a natural occurring spermine derivative, acts as a potent inhibitor of trypanothione reductase (Ki, 1.8 μM), with antihypertensive activity[1]. Kukoamine A is a natural occurring spermine derivative, acts as a potent inhibitor of trypanothione reductase (Ki, 1.8 μM), with antihypertensive activity[1].

Kukoamine B

Benzenepropanamide, N-(3-aminopropyl)-N-(4-((3-((3-(3,4-dihydroxyphenyl)-1-oxopropyl)amino)propyl)amino)butyl)-3,4-dihydroxy-

C28H42N4O6 (530.3104)

Kukoamine B (KB), a natural alkaloid compound with high affinity for both LPS and CpG DNA, was isolated from a traditional Chinese herb cortex Lycii. Kukoamine B, a novel dual inhibitor of LPS and CpG DNA, is a potential candidate for sepsis treatment. (PMID: 7487870) UK scientists at the Institute for Food Research have identified blood pressure-lowering compounds called kukoamines in potatoes. Previously only found in Lycium chinense, an exotic herbal plant whose bark is used to make an infusion in Chinese herbal medicine (http://www.whfoods.com/genpage.php?tname=foodspice&dbid=48) Kukoamine B is an amine. Kukoamine B is a natural product found in Lycium chinense and Solanum tuberosum with data available. Kukoamine B is a component of Lycii Cortex, with anti-oxidant, anti-acute inflammatory and anti-diabetic properties[1]. Kukoamine B is a component of Lycii Cortex, with anti-oxidant, anti-acute inflammatory and anti-diabetic properties[1].

L-Oleandrosyl-oleandolide

C27H46O10 (530.3091)

Kukoamine C

N-(3-aminopropyl)-N-{4-[N-(3-aminopropyl)-3-(3,4-dihydroxyphenyl)propanamido]butyl}-3-(3,4-dihydroxyphenyl)propanamide

C28H42N4O6 (530.3104)

Kukoamine C is an alkaloid from the root bark of Lycium chinense (Chinese boxthorn). UK scientists at the Institute for Food Research have identified blood pressure-lowering compounds called kukoamines in potatoes. Previously only found in Lycium chinense, an exotic herbal plant whose bark is used to make an infusion in Chinese herbal medicine. (http://www.whfoods.com/genpage.php?tname=foodspice&dbid=48)

Kukoamine D

N-[3-(N-{4-[(3-aminopropyl)amino]butyl}-3-(3,4-dihydroxyphenyl)propanamido)propyl]-3-(3,4-dihydroxyphenyl)propanamide

C28H42N4O6 (530.3104)

Kukoamine D is an alkaloid from the root bark of Lycium chinense (Chinese boxthorn). UK scientists at the Institute for Food Research have identified blood pressure-lowering compounds called kukoamines in potatoes. Previously only found in Lycium chinense, an exotic herbal plant whose bark is used to make an infusion in Chinese herbal medicine. (http://www.whfoods.com/genpage.php?tname=foodspice&dbid=48)

(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside]

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C27H46O10 (530.3091)

(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is found in fruits. (S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). (S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside] is found in loquat and fruits.

3-keto Fusidic acid

(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-3-oxohept-5-enoic acid

C31H46O7 (530.3243)

3-keto Fusidic acid is a metabolite of fusidic acid. Fusidic acid is a bacteriostatic antibiotic that is often used topically in creams and eyedrops, but may also be given systemically as tablets or injections. The global problem of advancing antimicrobial resistance has led to a renewed interest in its use recently. (Wikipedia)

(-)-Neolinderatin

[1S-[1alpha(1R*,6R*),6beta]]-3-Phenyl-1-[2,4,6-trihydroxy-3,5-bis[3-methyl-6-(1-methylethyl)-2-cyclohexen-1-yl]phenyl]-1-propanone

C35H46O4 (530.3396)

Kukoamine B

1,10-Bis(dihydrocaffeoyl)spermine

C28H42N4O6 (530.3104)

Kukoamine B is a component of Lycii Cortex, with anti-oxidant, anti-acute inflammatory and anti-diabetic properties[1]. Kukoamine B is a component of Lycii Cortex, with anti-oxidant, anti-acute inflammatory and anti-diabetic properties[1].

Neolinderatin

Lys Ile Arg Asp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]pentanamido]butanedioic acid

C22H42N8O7 (530.3176)

Ile Gly Thr Leu Asn

C23H42N6O8 (530.3064)

Ser Ile Arg Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H42N10O6 (530.3289)

Val Thr Arg Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H42N10O6 (530.3289)

Lys Glu Val Arg

(4S)-4-{[(1S)-1-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H42N8O7 (530.3176)

NSC163512

C31H46O7 (530.3243)

Gln Lys Leu Glu

C23H42N6O8 (530.3064)

Glu Val Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]hexanamido]-5-carbamimidamidopentanoic acid

C22H42N8O7 (530.3176)

Gln Leu Glu Lys

C23H42N6O8 (530.3064)

Leu Gln Glu Lys

C23H42N6O8 (530.3064)

Lys Leu Thr Arg

C23H46N8O6 (530.354)

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]propanoic acid

C25H38N8O5 (530.2965)

Trp Val Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]hexanoic acid

C27H42N6O5 (530.3217)

11-KETOROCKOGENIN ACETATE

C31H46O7 (530.3243)

(S)-Nerolidol 3-O-[a-L-rhamnopyranosyl-(1->2)-b-D-glucopyranoside]

2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-{[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]oxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C27H46O10 (530.3091)

3-O-alpha-L-rhamnopyranosyl-3-hydroxy-7Z-dodecenoyl-3-hydroxydecanoic acid

C28H50O9 (530.3455)

3-O-alpha-L-rhamnopyranosyl-3-hydroxy-5Z-dodecenoyl-3-hydroxydecanoic acid

C28H50O9 (530.3455)

ST 31:5;O7

(3S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-5-ene-3,22,25-triol 3,22-diacetate

C28H42N4O6 (530.3104)

Kukoamine D

C28H42N4O6 (530.3104)

3-O-(alpha-L-oleandrosyl)oleandolide

C27H46O10 (530.3091)

A macrolide that is oleandolide having a 2,6-dideoxy-3-O-methyl-alpha-Larabino-hexopyranosyl (alpha-L-oleandrosyl) residue attached at position 3.

PMe(24:3)

(2r,5z)-2-[(2r,3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-7-hydroxy-5-(hydroxymethyl)-6-methylhept-5-enoic acid

(5z)-3-[(1e)-2-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethenyl]-5-[(2e,4e,6e)-9-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-7-methylnona-2,4,6-trien-8-yn-1-ylidene]furan-2-one

(5z)-3-[(1e)-2-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethenyl]-5-[(2e,4e,6e)-9-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-7-methylnona-2,4,6-trien-8-yn-1-ylidene]furan-2-one

C34H42O5 (530.3032)

methyl (6r)-6-[(1r,3ar,4s,5ar,9as,10s,11ar)-4,10-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C31H46O7 (530.3243)

methyl (6r)-6-[(3s,3ar,4s,7s,9as,11ar)-3,4,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-10-oxo-3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C31H46O7 (530.3243)

(2s,3s)-4-methylidene-5-oxo-2-[(14s)-14-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentadecyl]oxolane-3-carboxylic acid

C27H46O10 (530.3091)

8β,9α-dihydroganodericacid j methyl ester

C31H46O7 (530.3243)

{"Ingredient_id": "HBIN013654","Ingredient_name": "8\u03b2,9\u03b1-dihydroganodericacid j methyl ester","Alias": "NA","Ingredient_formula": "C31H46O7","Ingredient_Smile": "CC(CC(=O)CC(C)C(=O)OC)C1CC(C2(C1(CC(=O)C3C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15073","TCMID_id": "5619","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acinospesigenin b

C31H46O7 (530.3243)

{"Ingredient_id": "HBIN014557","Ingredient_name": "acinospesigenin b","Alias": "NA","Ingredient_formula": "C31H46O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C=O)O)O)C)C)C2C1)C)C(=O)O)C(=O)OC","Ingredient_weight": "530.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14171","TCMID_id": "547","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21581816","DrugBank_id": "NA"}

methyl (2r,6r)-6-[(1r,3s,3ar,4r,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C31H46O7 (530.3243)

4-methylidene-5-oxo-2-(14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentadecyl)oxolane-3-carboxylic acid

C27H46O10 (530.3091)

methyl (4r)-4-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate

C30H42O8 (530.288)

(1r,2r,6s,10s,11r,12r,13s,14r,15r)-12-[(acetyloxy)methyl]-1-hydroxy-4,8,12,15-tetramethyl-14-[(2-methylpropanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylpropanoate

(1r,2r,6s,10s,11r,12r,13s,14r,15r)-12-[(acetyloxy)methyl]-1-hydroxy-4,8,12,15-tetramethyl-14-[(2-methylpropanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylpropanoate

n-[3-({4-[(3-{[1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethylidene]amino}propyl)amino]butyl}amino)propyl]-2-(4-hydroxy-3-methoxyphenyl)ethanimidic acid

C28H42N4O6 (530.3104)

4-{15-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-8,12-dimethyl-2,6-dioxahexacyclo[9.8.0.0¹,³.0³,⁸.0⁵,⁷.0¹²,¹⁷]nonadecan-7-yl}-5h-furan-2-one

C30H42O8 (530.288)

(1s,2r,6s,7r,9r,11r,12s,13s,15r,16r)-6-hydroxy-15-[(1s)-1-[(1s,2s,4r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-13-yl acetate

(1s,2r,6s,7r,9r,11r,12s,13s,15r,16r)-6-hydroxy-15-[(1s)-1-[(1s,2s,4r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-13-yl acetate

C30H42O8 (530.288)

(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxane-3,4,5-triol

C27H46O10 (530.3091)

methyl 6-{3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoate

C31H46O7 (530.3243)

5-[(1r,3as,3bs,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one

5-[(1r,3as,3bs,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one

[(1s,2r,5s,6s,7r,9r,11s,12s,15r,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,6-dihydroxy-2-methyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-16-yl]methyl acetate

(1r,3z,7s,8s,10r,11s,12s,16s,18r)-11,12-dihydroxy-8-[(1e)-2-[(2s,6r)-6-hydroxy-4-methyl-3,6-dihydro-2h-pyran-2-yl]ethenyl]-16-methyl-14-methylidene-6,9,22-trioxatricyclo[16.3.1.1⁷,¹⁰]tricosa-3,20-dien-5-one

4-[(1s,3r,7r,10s,11s,13r,14r,16r)-13-hydroxy-14-{[(2s,4r,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-7,11-dimethyl-2-oxapentacyclo[8.8.0.0¹,³.0³,⁷.0¹¹,¹⁶]octadec-5-en-6-yl]-5h-furan-2-one

4-[(1s,3r,7r,10s,11s,13r,14r,16r)-13-hydroxy-14-{[(2s,4r,5s,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-7,11-dimethyl-2-oxapentacyclo[8.8.0.0¹,³.0³,⁷.0¹¹,¹⁶]octadec-5-en-6-yl]-5h-furan-2-one

C31H46O7 (530.3243)

n-[3-({4-[n-(3-aminopropyl)-3-(3,4-dihydroxyphenyl)propanamido]butyl}amino)propyl]-3-(3,4-dihydroxyphenyl)propanimidic acid

C28H42N4O6 (530.3104)

6-{7,17-dihydroxy-6,6,10,14,18-pentamethyl-13-oxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadeca-11,15-dien-15-yl}-6-hydroxy-2-methyl-4-oxoheptanoic acid

C30H42O8 (530.288)

(1s,2s,6r,10s,11r,13s,14r,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-[(2-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl (2e)-2-methylbut-2-enoate

(1s,2s,6r,10s,11r,13s,14r,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-[(2-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl (2e)-2-methylbut-2-enoate

C30H42O8 (530.288)

(2s,6s)-6-[(1r,3r,5r,7s,10s,13s,14r,18r)-7,13-dihydroxy-6,6,10,14,18-pentamethyl-17-oxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadeca-11,15-dien-15-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid

(2s,6s)-6-[(1r,3r,5r,7s,10s,13s,14r,18r)-7,13-dihydroxy-6,6,10,14,18-pentamethyl-17-oxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadeca-11,15-dien-15-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid

C30H42O8 (530.288)

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-2,7,7,11,16-pentamethyl-5-oxo-15-[(3s)-5-oxooxolan-3-yl]-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C30H42O8 (530.288)

(1r,3s,3as,3br,5r,5ar,9ar,9bs,11ar)-1-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-3a,5,5a-trihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

(1r,3s,3as,3br,5r,5ar,9ar,9bs,11ar)-1-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-3a,5,5a-trihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl acetate

methyl (2r,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C31H46O7 (530.3243)